Cerevast Therapeutics, Inc.

Redmond, Washington 98052-2431

0 studies enrolling now · 1 studies all time

What they study most

Acute Ischemic Stroke

Studies at this site

• Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke — Stopped early